Cambridge Investment Research Advisors’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $334K | Buy |
1,529
+170
| +13% | +$37.1K | ﹤0.01% | 2890 |
|
|
2025
Q1 | $304K | Sell |
1,359
-281
| -17% | -$62.9K | ﹤0.01% | 2853 |
|
|
2024
Q4 | $537K | Sell |
1,640
-52
| -3% | -$17K | ﹤0.01% | 2371 |
|
|
2024
Q3 | $508K | Sell |
1,692
-357
| -17% | -$107K | ﹤0.01% | 2407 |
|
|
2024
Q2 | $675K | Sell |
2,049
-5,900
| -74% | -$1.94M | ﹤0.01% | 2055 |
|
|
2024
Q1 | $3.15M | Buy |
7,949
+5,513
| +226% | +$2.18M | 0.01% | 1006 |
|
|
2023
Q4 | $858K | Sell |
2,436
-322
| -12% | -$113K | ﹤0.01% | 1751 |
|
|
2023
Q3 | $1.04M | Sell |
2,758
-84
| -3% | -$31.5K | ﹤0.01% | 1555 |
|
|
2023
Q2 | $1.09M | Sell |
2,842
-303
| -10% | -$116K | 0.01% | 1553 |
|
|
2023
Q1 | $1.09M | Sell |
3,145
-2,717
| -46% | -$942K | 0.01% | 1522 |
|
|
2022
Q4 | $1.38M | Buy |
5,862
+2,150
| +58% | +$506K | 0.01% | 1303 |
|
|
2022
Q3 | $913K | Sell |
3,712
-484
| -12% | -$119K | 0.01% | 1542 |
|
|
2022
Q2 | $1.27M | Sell |
4,196
-1,461
| -26% | -$442K | 0.01% | 1303 |
|
|
2022
Q1 | $2.32M | Sell |
5,657
-699
| -11% | -$287K | 0.01% | 1051 |
|
|
2021
Q4 | $2.98M | Sell |
6,356
-1,426
| -18% | -$669K | 0.01% | 925 |
|
|
2021
Q3 | $3.3M | Buy |
7,782
+3,693
| +90% | +$1.57M | 0.02% | 819 |
|
|
2021
Q2 | $1.47M | Sell |
4,089
-629
| -13% | -$226K | 0.01% | 1284 |
|
|
2021
Q1 | $1.33M | Buy |
4,718
+563
| +14% | +$159K | 0.01% | 1247 |
|
|
2020
Q4 | $1.18M | Buy |
4,155
+181
| +5% | +$51.3K | 0.01% | 1201 |
|
|
2020
Q3 | $1.09M | Buy |
3,974
+408
| +11% | +$112K | 0.01% | 1139 |
|
|
2020
Q2 | $810K | Sell |
3,566
-205
| -5% | -$46.6K | 0.01% | 1259 |
|
|
2020
Q1 | $574K | Buy |
3,771
+200
| +6% | +$30.4K | 0.01% | 1282 |
|
|
2019
Q4 | $537K | Buy |
3,571
+768
| +27% | +$115K | ﹤0.01% | 1534 |
|
|
2019
Q3 | $398K | Sell |
2,803
-43
| -2% | -$6.11K | ﹤0.01% | 1651 |
|
|
2019
Q2 | $356K | Buy |
2,846
+290
| +11% | +$36.3K | ﹤0.01% | 1643 |
|
|
2019
Q1 | $282K | Sell |
2,556
-750
| -23% | -$82.7K | ﹤0.01% | 1856 |
|
|
2018
Q4 | $324K | Buy |
3,306
+382
| +13% | +$37.4K | ﹤0.01% | 1614 |
|
|
2018
Q3 | $361K | Sell |
2,924
-1,181
| -29% | -$146K | ﹤0.01% | 1664 |
|
|
2018
Q2 | $408K | Buy |
4,105
+29
| +0.7% | +$2.88K | ﹤0.01% | 1523 |
|
|
2018
Q1 | $360K | Sell |
4,076
-143
| -3% | -$12.6K | ﹤0.01% | 1535 |
|
|
2017
Q4 | $416K | Buy |
4,219
+336
| +9% | +$33.1K | ﹤0.01% | 1430 |
|
|
2017
Q3 | $374K | Buy |
3,883
+510
| +15% | +$49.1K | 0.01% | 1420 |
|
|
2017
Q2 | $319K | Buy |
3,373
+804
| +31% | +$76K | ﹤0.01% | 1472 |
|
|
2017
Q1 | $210K | Buy |
2,569
+40
| +2% | +$3.27K | ﹤0.01% | 1584 |
|
|
2016
Q4 | $215K | Buy |
+2,529
| New | +$215K | ﹤0.01% | 1463 |
|
|
2016
Q3 | – | Sell |
-2,704
| Closed | -$205K | – | 1793 |
|
|
2016
Q2 | $205K | Buy |
+2,704
| New | +$205K | ﹤0.01% | 1367 |
|